"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,WO,A1,WO 1996/039416 A1,133-362-594-960-886,1996-12-12,1996,US 9608191 W,1996-05-31,US 47022795 A,1995-06-06,GENE THERAPY FOR PITUITARY ADENOMA AND OTHER ENDOCRINE DISORDERS,"Virus vectors containing selected genes encoding proteins capable of modulating pituitary tumor or gland physiology and methods for using these vectors in the treatment of pituitary adenomas, pituitary hyperfunction and hypofunction, dysfunction of the hypothallamic/pituitary axis, and neuroendocrine diseases mediated by the pituitary gland are provided.",UNIV PENNSYLVANIA;;UNIV YALE,FREESE ANDREW;;FLAMM EUGENE S;;SNYDER PETER J;;GENNARELLI THOMAS;;DURING MATTHEW J,,https://lens.org/133-362-594-960-886,Patent Application,yes,1,1,3,3,0,A61K48/00;;C12N9/0071,A61K48/00;;C12N9/02,,3,3,065-216-924-366-258;;020-404-203-384-97X;;024-360-200-582-886,10.1046/j.1471-4159.1994.62030863.x;;7509376;;pmc6576430;;7902865;;10.1523/jneurosci.13-12-05203.1993;;7518394;;10.1006/exnr.1994.1097,"JOURNAL OF NEUROCHEMISTRY, 1994, Vol. 62, No. 3, WU et al., ""The Stability of Endogenous Tyrosine Hydroxylase Protein in PC-12 Cells Differs from that Expressed in Mouse Fibroblasts by Gene Transfer"", pages 863-872.;;THE JOURNAL OF NEUROSCIENCE, December 1993, Vol. 13, No. 12, KANG et al., ""Regulation of Dopamine Production by Genetically Modified Primary Fibroblasts"", pages 5203-5211.;;EXPERIMENTAL NEUROLOGY, June 1994, Vol. 127, No. 2, ANTON et al., ""Neural-Targeted Gene Therapy for Rodent and Primate Hemiprkinsonism"", pages 207-218.",PENDING
2,CA,A1,CA 2221604 A1,115-240-126-213-064,1996-12-12,1996,CA 2221604 A,1996-05-31,US 47022795 A,1995-06-06,GENE THERAPY FOR PITUITARY ADENOMA AND OTHER ENDOCRINE DISORDERS,"Virus vectors containing selected genes encoding proteins capable of modulating pituitary tumor or gland physiology and methods for using these vectors in the treatment of pituitary adenomas, pituitary hyperfunction and hypofunction, dysfunction of the hypothallamic/pituitary axis, and neuroendocrine diseases mediated by the pituitary gland are provided.",UNIV PENNSYLVANIA;;UNIV YALE,FREESE ANDREW;;GENNARELLI THOMAS;;SNYDER PETER J;;FLAMM EUGENE S;;DURING MATTHEW J,,https://lens.org/115-240-126-213-064,Patent Application,no,0,0,3,3,0,A61K48/00;;C12N9/0071,A61K48/00;;C12N9/02,,0,0,,,,DISCONTINUED
3,AU,A,AU 1996/060282 A,029-886-297-556-366,1996-12-24,1996,AU 1996/060282 A,1996-05-31,US 47022795 A;;US 9608191 W,1995-06-06,Gene therapy for pituitary adenoma and other endocrine disor ders,,UNIV PENNSYLVANIA;;UNIV YALE,FREESE ANDREW;;FLAMM EUGENE S;;SNYDER PETER J;;GENNARELLI THOMAS;;DURING MATTHEW J,,https://lens.org/029-886-297-556-366,Patent Application,no,0,0,3,3,0,A61K48/00;;C12N9/0071,A61K48/00;;C12N9/02,,0,0,,,,PENDING
